BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 227231)

  • 1. The mechanism of the release of hepatic enzymes in various liver diseases. 1. Alterations in cytoplasmic and mitochondrial enzyme activities in serum.
    Miyake S
    Acta Med Okayama; 1979 Aug; 33(4):287-304. PubMed ID: 227231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of release of hepatic enzymes in various liver diseases. II. Altered activity ratios of GOT to GPT in serum and liver of patients with liver diseases.
    Miyake S
    Acta Med Okayama; 1979 Oct; 33(5):343-58. PubMed ID: 160182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic transaminase activity in alocholic liver disease.
    Matloff DS; Selinger MJ; Kaplan MM
    Gastroenterology; 1980 Jun; 78(6):1389-92. PubMed ID: 7372058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavior of some mitochondrial enzymes in the blood of patients with various liver diseases].
    De Franchis R; Tornaghi G; Bellobuono A; Bitto T; Mirabile E; Del Ninno E; Ideo G
    Quad Sclavo Diagn; 1972 Mar; 8(1):262-70. PubMed ID: 4663755
    [No Abstract]   [Full Text] [Related]  

  • 5. [The diagnostic value of glutamic acid dehydrogenase].
    Rettenbacher-Däubner H; Rieder H; Sburny I
    Acta Hepatosplenol; 1967; 14(4):209-21. PubMed ID: 4297959
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isoenzymes in hepatitis. I. Enzymekinetic cytoplasmic and mitochondrial enzymes in serum].
    Kleine FD
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):197-202. PubMed ID: 5732397
    [No Abstract]   [Full Text] [Related]  

  • 7. Isoenzymes of aspartate aminotransferase in chronic liver diseases.
    Skrha J; Stĕpán J; Volek V
    Acta Hepatogastroenterol (Stuttg); 1978 Apr; 25(2):127-9. PubMed ID: 654844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of type III procollagen peptide in sera of patients with liver cancer].
    Yamauchi M; Nakayama H; Fukuzawa K; Nakajima H; Takahara M; Nakahara M; Kawase H; Watanabe Y; Kimura K; Kitahara T
    Gan No Rinsho; 1984 Jun; 30(7):785-90. PubMed ID: 6086978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatic GOT and GPT activities in patients with various liver diseases--especially alcoholic liver disease].
    Takahashi A; Sekiya C; Yazaki Y; Ono M; Sato H; Hasebe C; Ishikawa Y; Okuno K; Yamada M; Namiki M
    Hokkaido Igaku Zasshi; 1986 May; 61(3):431-6. PubMed ID: 3744290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial glutamic oxaloacetic transaminase and its clinical significance.
    Sekiya C; Yasaki Y; Numazaki A; Takahashi A; Takasugi Y; Namiki M; Mima S; Hanyu T; Tanabe Y
    Hokkaido Igaku Zasshi; 1979 May; 54(3):245-51. PubMed ID: 533708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of the determination of serum guanase activity. Studies on patients and experimental data from mongrel dogs and cultured rat hepatocytes.
    Ito S; Takaoka T; Nakaya Y; Hiasa Y; Mori H; Tanaka K; Ichihara A
    Gastroenterology; 1982 Nov; 83(5):1102-8. PubMed ID: 6288507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activity of mitochondrial aspartate aminotransferase isoenzyme in chronic liver diseases].
    Volek V; Stĕpán J; Skrha J
    Vnitr Lek; 1976 Dec; 22(12):1179-84. PubMed ID: 1007052
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activity interrelation of serum GOT and GPT transaminases in chronic liver diseases and their significance in liver cirrhosis].
    Busch D; Fernbacher K
    Verh Dtsch Ges Inn Med; 1969; 75():347-50. PubMed ID: 5400148
    [No Abstract]   [Full Text] [Related]  

  • 14. [Statistical evaluation of glutamic-oxaloacetic and glutamic-pyruvic serum transaminase in some diseases of the digestive system].
    Barisone D; Accardo S; Schenardi C
    Arch Maragliano Patol Clin; 1969; 25(4):297-315. PubMed ID: 5408925
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitochondrial/cytoplasmic enzyme ratio for the diagnosis of acute rejection after liver transplantation: sensitivity and specificity.
    Avolio AW; Gozzo ML; Forni L; Agnes S; Colacicco L; Barbaresi G; Magalini SC; Castagneto M
    Transplant Proc; 1992 Dec; 24(6):2572-3. PubMed ID: 1361263
    [No Abstract]   [Full Text] [Related]  

  • 16. [Critical evaluation of the serum enzymatic diagnosis of liver diseases].
    Sposito M; Albertini Petroni V; Hassan G; Marinucci G; Valeri L
    Quad Sclavo Diagn; 1971 Dec; 7(4):1036-49. PubMed ID: 4144704
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinico-pathological studies of LEC rats with hereditary hepatitis and hepatoma in the acute phase of hepatitis.
    Kasai N; Osanai T; Miyoshi I; Kamimura E; Yoshida MC; Dempo K
    Lab Anim Sci; 1990 Sep; 40(5):502-5. PubMed ID: 2170750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum glutamic-oxaloacetic transaminase (GOT) and glutamic-pyruvic transaminase (GPT) levels in children and adolescents with intellectual disabilities.
    Lin JD; Lin PY; Chen LM; Fang WH; Lin LP; Loh CH
    Res Dev Disabil; 2010; 31(1):172-7. PubMed ID: 19828286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A liver-specific antigen in the serum of patients with liver disease].
    Rosenmund A
    Schweiz Med Wochenschr; 1971 Jul; 101(28):1023-6. PubMed ID: 5003908
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical significance of serum guanase activity in various liver diseases.
    Shiota G; Fukada J; Ito T; Tsukizawa M; Yamada M; Sato M
    Jpn J Med; 1989; 28(1):22-4. PubMed ID: 2542677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.